Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +25.00%
#4 Nockchain Nockchain +18.92%
#5 Velvet Velvet +18.00%
#6 Perle Perle +14.46%
#7 FOLKS FOLKS +13.61%
#8 Nillion Nillion +12.50%
#9 Versatize Coin Versatize Coin +12.49%
#10 Starpower Starpower +10.78%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Erech Finance Cahalacha Ltd Erech Finance Cahalacha Ltd

Erech Finance Cahalacha Ltd

EFNC
Rank in Stocks #37366
Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse... Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse lending and credit solutions to small and medium-sized businesses, associations, and individual clients across Israel. The company's operations are structured into two main divisions: Non-Bank Credit and Biomed Drug. Additionally, Erech Finance Cahalacha Ltd is engaged in pharmaceutical research and development, concentrating on treatments for diabetes and cancer. Its corporate headquarters are located in Jerusalem, Israel.
Share Price
$0.703043
Last synced: 2024-08-19
Market Cap
$1.78M
Change (1 day)
-1.18%
Change (1 year)
0.00%
Country
IL
Trade Erech Finance Cahalacha Ltd (EFNC)

Category

Healthcare
P/S ratio for Erech Finance Cahalacha Ltd (EFNC)
P/S ratio as of 2026 TTM: 0
According to Erech Finance Cahalacha Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Erech Finance Cahalacha Ltd from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 -
US